HSP90 antibody
Quick Overview for HSP90 antibody (ABIN7618916)
Target
See all HSP90 AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    
- 
                                            
Purpose
 - Heat Shock Protein 90 (HSP90) Polyclonal Antibody
 - 
                                            
Characteristics
 - The Heat Shock Protein 90 (HSP90) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
 - 
                                            
Purification
 - Affinity Chromatography
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - Optimal working dilution should be determined by the investigator.
 - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Concentration
 - 0.36 mg/mL
 - 
                                            
Buffer
 - 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
 - 
                                            
Preservative
 - ProClin
 - 
                                            
Precaution of Use
 - This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Storage
 - 4 °C,-20 °C
 - 
                                            
Storage Comment
 - 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
 - 
                                            
Expiry Date
 - 12 months
 
 - 
                                            
 - 
    
- HSP90 (Heat Shock Protein 90 (HSP90))
 - 
                                            
Alternative Name
 - HSP90
 - 
                                            
Gene ID
 - 3320
 - 
                                            
UniProt
 - P07900
 - 
                                            
Pathways
 - M Phase, Regulation of Cell Size, Signaling Events mediated by VEGFR1 and VEGFR2, VEGFR1 Specific Signals
 
Target
 -